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The rat [~-tropomyosin gene encodes two isoforms, termed skeletal muscle 13-tropomyosin and fibroblast last 
tropomyosin 1 (TM-1), via an alternative RNA processing mechanism. The gene contains 11 exons. Exons 1-5 
and exons 8 and 9 are common to all mRNAs expressed from the gene. Exons 6 and 11 are used in fibroblasts, 
as well as smooth muscle, whereas exons 7 and 10 are used only in skeletal muscle. In the present studies we 
focused on the mutually exclusive internal alternative splice choice involving exon 6 (fibroblast-type splice) and 
exon 7 (skeletal muscle-type splice). We have identified two distinct elements in the intron, upstream of exon 
7, involved in splice site selection. The first element is comprised of a polypyrimidine tract located 89-143 
nucleotides upstream of the 3' splice site, which specifies the location of the lariat branchpoints used, 144-153 
nucleotides upstream of exon 7. The 3' splice site AG dinucleotide has no role in selection of these 
branchpoints. The second element is comprised of intron sequences located between the polypyrimidine tract 
and the 3' splice site of exon 7. It contains an important determinant in alternative splice site selection, because 
deletion of these sequences results in the use of the skeletal muscle-specific exon in nonmuscle cells. We 
propose that the use of lariat branchpoints located far upstream from a 3' splice site may be a general feature of 
some alternatively excised introns, reflecting the presence of regulatory sequences located between the lariat 
branch site and the 3' splice site. The data also indicate that alternative splicing of the rat ~-tropomyosin gene 
is regulated by a somewhat different mechanism from that described for rat ~-tropomyosin gene and the 
transformer-2 gene of Drosophila melanogaster. 
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A growing number of cellular and viral genes have been 
characterized that encode multiple protein isoforms via 
the use of alternatively spliced exons (for reviews, see 
Ziff 1980; Left et al. 1986; Breitbart et al. 1987). In many 
cases, alternative RNA splicing contributes to develop- 
mentally regulated and tissue-specific patterns of gene 
expression. At present, the molecular basis for alterna- 
tive splice site selection is not known, although a great 
deal of information is available concerning the general 
splicing reaction of simple transcription units (for re- 
views, see Green 1986; Padgett et al. 1986; Krainer and 
Maniatis 19881. 
In simple transcription units, splice site selection is 
achieved through the recognition of highly conserved 
sequences at the 5' and 3' splice junctions by different 
cellular factors (Breathnach and Chambon 1981; Mount 
1982; Keller and Noon 1984; Green 1986; Padgett et al. 
1986). Thus, the 5' splice site consensus equence AG/ 
GTPuAGT, has been shown to interact with the 5' end 
of the U1 small nuclear RNA (Mount et al. 1983; Black 
et al. 1985; Zhuang et al. 1987; Seraphin et al. 1988), 
whereas the 3' splice site consensus (Py)nNPyAG/G 
(Breathnach and Chambon 1981; Mount 1982)interacts 
with several cellular factors whose precise nature has 
not been completely established. One of these, however, 
is a 70- to 100-kD protein that is probably associated 
with the U5 small nuclear ribonucleoprotein (snRNP) 
(Gerke and Steitz 1986; Tazi et al. 1986). In addition, 
analysis of the branchpoints in a number of cellular and 
viral genes identified a loosely conserved sequence PyN- 
PyUPuAPy, with the adenosine residue usually serving 
as the site of branchpoint formation 18-40 nucleotides 
upstream of a 3' splice site (Keller and Noon 1984; Reed 
and Maniatis 1985; Ruskin et al. 1985). U2 snRNP is 
thought o interact with the pre-mRNA at the branch- 
point region, most likely through direct base-pairing 
with the pre-mRNA (Black et al. 1985; Konarska and 
Sharp 1986; Parker et al. 1987; Bindereif and Green 
1987; Hartmuth and Barta 1988; Wu and Manley 1989; 
Zhuang and Weiner 1989). In addition, a factor termed 
U2AF (U2 snRNP auxiliary factor) has been reported to 
be necessary for the binding of U2 snRNP to the branch- 
point and for splicing complex assembly (Ruskin et al. 
19881. 
At present little is known about the mechanisms that 
are responsible for the selection of alternative splice 
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sites in complex transcription units and how the 
splicing signals in alternatively spliced exons differ from 
those in constitutively spliced exons. Sequence compar- 
isons between splice junctions of alternative and consti- 
tutive exons have failed to reveal any significant differ- 
ences, suggesting that the regulation of splice site selec- 
tion in transcripts containing alternative 5' or 3' splice 
sites will involve other cis-acting elements (Breitbart et 
al. 1987). A number of features in the pre-mRNA may be 
involved in alternative splice site selection, including 
intron size (Fu and Manely 1987), the relative strengths 
of 5' splice sites (Zhuang et al. 1987), the pyrimidine 
content of a 3' splice site (Fu et al. 1988), location of 
branchpoints (Gattoni et al. 1988; Helfman and Ricci 
1989; Smith and Nadal-Ginard 1989), multiple alterna- 
tive branchpoints (Noble et al. 1987 1988; Gattoni et al. 
1988; Helfman and Ricci 1989), branchpoint sequences 
(Reed and Maniatis 1988; Zhuang et al. 1989), and exon 
sequences (Somasekhar and Mertz 1985; Reed and Man- 
iatis 1986; Mardon et al. 1987; Helfman et al. 1988; 
Cooper and Ordahl 1989; Hampson et al. 1989; Streuli 
and Saito 1989). In addition, exon and intron sequences 
could play a role in alternative splicing by regulating the 
accessibility of different exons to the splicing machinery 
by the formation of RNA secondary structures (Khoury 
et al. 1979; Munroe 1984; Solnick 1985; Eperon et al. 
1986, 1988; Edlind et al. 1987; Left et al. 1987). 
We have used the rat 13-tropomyosin gene as a model 
to investigate developmental nd tissue-specific alterna- 
tive splicing (Helfman et al. 1986, 1988; Helfman and 
Ricci 1989). This gene spans 10 kb with 11 exons and 
encodes two distinct isoforms, namely skeletal muscle 
[3-tropomyosin and fibroblast TM-1 (see Fig. 1). Exons 
1-5, 8, and 9 are common to all mRNAs expressed from 
this gene. Exons 6 and 11 are used in fibroblasts, as well 
as smooth muscle, whereas exons 7 and 10 are used ex- 
clusively in skeletal muscle. Our previous studies of tro- 
pomyosin pre-mRNA splicing in vitro, using HeLa cell 
systems, revealed an ordered pathway of splicing in 
which either of the internal alternatively spliced exons 
(exon 6 or 7) must first be joined to the downstream 
common exon before they can be spliced to the up- 
stream common exon (Helfman et al. 1988). We charac- 
terized the branchpoints formed during use of these al- 
ternatively spliced exons. The splicing of exon 5 to exon 
7 (skeletal muscle-type splice) is accompanied by the se- 
lection of multiple branchpoints, which are located an 
Regulation of alternative RNA splicing 
unusually long distance (144, 147, and 153 nucleotides) 
from the 3' splice site of exon 7 (Helfman and Ricci 
1989). These results are different from most branch- 
points mapped, in which a single adenosine residue lo- 
cated 18-40 nucleotides from a 3' splice site is used 
during lariat formation. 
We have now investigated the functional role of the 
intron sequences between the unusual branchpoints and 
the 3' splice site of the skeletal muscle exon (exon 7) in 
splice site selection of the rat 13-tropomyosin pre- 
mRNA. Our results indicate that two distinct elements 
are present in this region. The first element is a polypyr- 
imidine tract that specifies the use of the branchpoints 
located far upstream from the 3' splice site; the second 
element is located immediately upstream of exon 7 and 
inhibits the use of the skeletal muscle exon (exon 7) in 
nonmuscle cells. The unusual ocation of these branch- 
points located far upstream from the 3' splice site in this 
and perhaps other alternatively excised introns thus re- 
flects the presence of new cis-acting elements located 
just upstream of the 3' splice site, which are involved in 
alternative splice site selection. 
Results 
The splicing of exon 5 to exon 7 (skeletal muscle-type 
splice) is associated with the use of multiple branch- 
points located 144-153 nucleotides upstream of the 3' 
splice site of exon 7 (Helfman and Ricci 1989). To deter- 
mine what sequences in intron 6 contributed to the use 
of these branchpoints, first we constructed a series of 
deletion mutants in which 53-167 nucleotides were re- 
moved upstream of the 3' splice site. All of these dele- 
tions from the 3' end of the intron maintained the last 7 
nucleotides of intron 6 at the 3' splice site of exon 7. The 
sequence of intron 6 and the position of the deletions are 
indicated in Figure 2. To determine whether sequences 
upstream of the branchpoint sequences affect the effi- 
ciency of splicing or the position of branch formation, a 
set of deletion mutants was constructed in which 
14-180 nucleotides were removed ownstream of the 5' 
splice site of exon 6. These deletions maintained the 
first 17 nucleotides of intron 6 at the 5' splice site of 
exon 6. The deletions were introduced into the plasmid 
pSP64-p2(7/8) for in vitro experiments and into plasmids 
pSV40-p2(7/8) and pSV40-p2 for in vivo analyses 
(Helfman et al. 1988). 
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Figure l. Schematic diagram of the rat ~-tropomyosin gene. Open boxes represent constitutive xons; hatched and solid boxes 
represent tissue-specific exons, as indicated. Horizontal lines represent introns (not drawn to scale). The amino acids encoded byeach 
exon are indicated. The cap site and polyadenylation sites are also indicated. 
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I I -241 cgucccuccccagcucagcaucucaggcuacugucucucuccugcgguag 
cd30 cd27 d85 d15 d84 
I I I  I * 1 " *  -191 gagggggcgggggcggagcuuccaaacagccugcugucacucucaucac_u_u 
d81 d92 cd22 
I I -141 uuqcucuucucuuuucuccuccuccccuccuccacuquqccaccccu[ccc 
d25 d29 d9 
I I I -91 ccuaaccccacccccucaccccgucgucgcgccaccccacugucucaccu 
-I 
-41 cacugugcccucacgcuccauccugccacacgccccugcag:EXON 7 
Figure 2. Nucleotide sequence of deletion mutants in intron 
6. The nucleotide sequence of intron 6 is shown, as well as the 
locations of the lariat branch sites used in the splicing of exon 5 
to exon 7 (*) and are located 144, 147, and 153 nucleotides from 
the 3' splice site of exon 7. The 55-nucleotide long polypyrimi- 
dine tract located 89-143 nucleotides upstream from the 3' 
splice site of exon 7 is underlined. Deletions beginning from the 
3' end of the intron are indicated: dg, d29, d25, d92, d81, d84, 
dlS, and d85. These deletions maintained the last 7 nucleotides 
of intron 6. Deletions from the 5' end of the intron are also 
indicated: cd21, cd3, cdl4, cd30, cd27, and cd22. These dele- 
tions maintained the first 17 nucleotides of intron 6. 
Intron sequences immediately upstream of the skeletal 
muscle specific exon are not required for splice site 
utilization in vitro and in vivo 
We demonstrated previously that exon 5 is spliced accu- 
rately and efficiently to exon 7 in HeLa cell nuclear ex- 
tracts, using pre-mRNAs derived from plasmid pSP64- 
p2(7/8) (Helfman et al. 1988). The products of the in 
vitro splicing reactions with the wild-type and mutant 
pre-mRNAs containing deletions immediately upstream 
of exon 7 are shown in Figure 3. In this experiment, 
RNA transcripts were incubated in the in vitro splicing 
reaction for 120 min. Following the splicing reactions, 
the RNA was fractionated on a 4% polyacrylamide/urea 
gel (Fig. 3, left). As shown in Figure 3, removal of up to 
116 nucleotides upstream of the 3' splice site of exon 7 
had little affect on splicing efficiency in vitro. On the 
other hand, pre-mRNAs containing deletions d15 and 
d85, which removed sequences upstream of the func- 
tional branched nucleotides, were not spliced at all, as 
indicated by the lack of a free 5' exon. In no case did we 
detect splicing of exon 5 to exon 6 with any of these 
precursors. These results are in agreement with our pre- 
vious observations that splicing of exon 5 to exon 6 (fi- 
broblast-type splice) absolutely requires that exon 6 first 
be joined to exon 8 (Helfman et al. 1988). Thus, splicing 
of exon 5 to exon 7 requires ome, but not all, sequences 
between the branchpoint sequences and 3' splice site. 
Next we determined whether the splicing of exon 5 to 
exon 7 in the various deletion mutants involves the use 
of the same branch sites. Precursors derived from the 
wild-type template and four competent splicing mutants 
(d9, d29, d25, and d92) were spliced in vitro and the 
products corresponding to the free lariat were isolated. 
Half of the RNA was analyzed directly, and the other 
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half was incubated in a HeLa cell S-100 fraction that 
contained a lariat debranching activity prior to primer 
extension analysis (Ruskin and Green 1985). Primer ex- 




Figure 3. In vitro splicing of pre-mRNAs containing deletions 
of intron sequences upstream of exon 7. The diagram at top 
represents the DNA templates derived from pSP64-p2{7/8) lin- 
earized with EcoRI. The position of the branchpoint sequences 
(BPS1 and adjacent polypyrimidine tract {shaded box) in intron 6 
are also indicated. In vitro splicing reactions were carried out 
for 2 hr, and the a2P-labeled RNA products were separated in a 
4% denaturing polyacrylamide gel. Schematic representation f 
the products and intermediates are indicated to the left of the 
autoradiographs and are {from top to bottoml pre-mRNA, 
lariat/exon intermediate, free lariat, free lariat but 3' end is de- 
graded up until the lariat branchpoints by 3' exonucleolytic ac- 
tivity, splice product, and free exon 5. {Lanes MI Markers using 
pBR322 digested with MspI. The isolated free lariat was ana- 
lyzed by primer extension using a a2P-labeled oligonucleotide 
complementary to sequences in intron 6 (rightl. Part of the 
RNA was treated with debranching activity from an S-100 frac- 
tion prior to reverse transcription. Analyses of branched RNA 
{ + ) and debranched RNA { - 1 for each pre-mRNA are indicated. 
The positions of the lariat branch nucleotides, located 144, 147, 
and 153 nucleotides upstream of the 3' splice site of the wild- 
type precursor, are indicated. At this level of exposure, the ex- 
pected band of 396 nucleotides corresponding to the 5' end of 
the linearized intron following treatment with debranching ac- 
tivity is not visible in this autoradiograph. 
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deoxyoligonucleotide complementary to sequences 
within intron 6. Reverse transcriptase has been shown 
to stop at branched nucleotides (Ruskin et al. 1985). As 
indicated in Figure 3 (right), splicing of exon 5 to exon 7 
with all five substrates involves the use of the same 
lariat branchpoints. Identical results were also obtained 
using the isolated lariat/exon intermediates (data not 
shown). Thus, the position of the lariat branchpoints 
used was specified independently of the distance be- 
tween the 3' splice site AG dinucleotide and the branch- 
point sequences. 
The effects of these intron deletions were also assayed 
in vivo. The different deletions were introduced into 
plasmid pSV40-2(7/8), which carries a minigene con- 
sisting of the SV40 early promoter and a functional 
poly(A) site flanking genomic tropomyosin sequences. In
previous tudies we demonstrated that in HeLa cells, the 
3' splice site of exon 7 was used efficiently in this con- 
struct (Helfman et al. 1988). HeLa cells were transfected 
with these seven plasmids, and theresulting transiently 
expressed cytoplasmic RNAs were isolated. The RNA 
protection analyses of these RNAs, as well as RNA iso- 
lated from mock-infected cells, were carried out with 
probes derived from eDNA clones encoding skeletal 
muscle f3-tropomyosin (Fig. 4). Transient expression of 
wild-type plasmid pSV40-p2(7/8) and deletions d9, d29, 
d25, and d92 in HeLa cells results in spliced RNA that 
contains exons 5 + 7 + 8 + 9. In contrast, deletions 
dl 5 and d85 did not yield spliced products corresponding 
to the splicing of exons 5 + 7 + 8 + 9. Thus, in agree- 
ment with the in vitro data presented above, the splicing 
of exon 5 to exon 7 in vivo requires ome, but not all, 
sequences between the branchpoint sequences and the 
3' splice site. 
Most sequences in the 5' end of intron 6 are not 
required for use of the skeletal muscle-specific exon 
in vitro 
We also introduced a series of deletions in plasmid 
pSP64-p2(7/8), starting near the 5' end of intron 6 (see 
Fig. 2). Pre-mRNAs derived from these 5'-intron deletion 
mutants were processed in vitro (Fig. 5). All but one de- 
letion mutant were accurately and efficiently spliced in 
vitro (Fig. 5, left). In addition, splicing of these pre- 
mRNAs is associated with the use of the same branch- 
points (Fig. 5, right). Pre-mRNAs derived from pSP64- 
p2(7/8)cd22 were not spliced at all. This deletion re- 
moved the functional branchpoints, including the 
adjacent downstream polypyrimidine tract. However, 
this deletion leaves intact a number of potential branch 
site sequences that are located closer to the 3' splice site 
of exon 7. For example, good branchpoint consensus se- 
quences are found at positions 29, 74, and 87 nucleotides 
upstream of the 3' splice site (see Fig. 2). Interestingly, 
these branchpoints were not selected, even in the ab- 
sence of the branch nucleotides usually used upstream 
of these sites. Because the intron sequences within the 
first 90 nucleotides upstream of exon 7 contain purines 
distributed every 2-7 nucleotides, the purines might 
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Figure 4. RNA analysis of HeLa cells transfected with tropo- 
myosin minigenes. (Top) Schematic diagram of the tropo- 
myosin minigenes used in the HeLa cell transfections. The po-
sition of the branchpoint sequences (BPS)and adjacent polypyr- 
imidine tract (shaded box) in intron 6 are also indicated. 
(Middle) Autoradiograph of RNA protection analyses, using 
probes derived from eDNA clone encoding rat skeletal muscle 
[3-tropomyosin of cytoplasmic RNAs from HeLa cells trans- 
fected with the minigenes, as indicated. The band corre- 
sponding to the reference ~-globin RNAs is labeled (a-globin). 
(Bottom) Schematic diagram of the structure of the RNA probe 
and protected fragments {labeled S in middle) corresponding to 
spliced RNA from the seven minigenes. 
disrupt the interaction of specific splicing factors with 
these sequences and thereby prevent heir use. This hy- 
pothesis is supported by recent studies indicating that 
substitution of purines in the polypyrimidine tract lo- 
cated at the 3' end of intron 1 of the adenovirus major 
late transcript affects the efficiency of the in vitro 
splicing reaction (Freyer et al. 1989). 
The branch site upstream of the skeletal muscle exon 
is specified independent of the 3' splice site A G 
dinucleotide 
The above results showed that deletion of most se- 
quences between the 3' splice site of exon 7 and the 
branchpoints did not affect he splicing of exon 5 to exon 
7. To further investigate the nature of the cis-acting se- 
quences that specify the location of the lariat branch 
points used in intron 6, a series of pre-mRNAs were 
transcribed from the deletions derived from pSP64-p2(7/ 
8) linearized with PstI. The PstI site (CTGCAG) is lo- 
cated at the 3' end on intron 6. These pre-mRNAs termi- 
nate 5 bases hort of the 3' end of the intron and have no 
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Figure 5. In vitro splicing of pre-mRNAs containing deletions 
of intron sequences downstream of exon 6. (Top) DNA tem- 
plates derived from pSP64-p2(7/8) linearized with EcoRI. The 
position of the branch point sequences (BPS) and adjacent poly- 
pyrimidine tract (shaded box) in intron 6 are also indicated. In 
vitro splicing reactions were carried out for 2 hr, and the 32P-la- 
beled RNA products were separated in a 4% denaturing poly- 
acrylamide gel. Schematic representation f the products and 
intermediates are indicated to the left of the autoradiographs 
and are (from top to bottom) pre-mRNA, lariat/exon interme- 
diate, free lariat, free lariat with the 3' end degraded up until 
the lariat branchpoints by 3' exonucleolytic activity, splice 
product, and free exon 5. (Lanes M) Markers using pBR322 di- 
gested with MspI. One-half of the reaction products were ana- 
lyzed by primer extension using a 32p-labeled oligonucleotide 
complementary to sequences in intron 6 (right). Part of the 
RNA was treated with debranching activity from an S-100 frac- 
tion prior to reverse transcription. Analyses of branched RNA 
( + ) and debranched RNA (-)  for each pre-mRNA are indicated. 
The positions of the lariat branch nucleotides, located 144, 147, 
and 153 nucleotoides upstream of the 3' splice site of the wild- 
type precursor, are indicated. At this level of exposure, the ex- 
pected band of 396 nucleotides corresponding to the 5' end of 
the linearized intron following treatment with debranching ac- 
tivity is not visible in this autoradiograph. 
downstream exon sequences. The products of the in 
vitro splicing reactions w i th  pre-mRNA transcripts from 
wild-type and mutant  pSP64-p2(7/8) l inearized wi th  PstI 
are shown in Figure 6. Interestingly, the wild-type pre- 
mRNAs  and deletions d9, d29, d25, and d92 went  
through the first step in splicing efficiently, result ing in 
cleavage at the 5' splice site of exon 5 and lariat forma- 
t ion (Fig. 6). On the other hand, deletions d15 and d85 
did not  exhibit  any splicing, as indicated by no detect- 
able cleavage at the 5' splice site of exon 5. In addition, 
4---- 
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Figure 6. The branch site upstream of the skeletal muscle 
exon is specified independent of the 3' splice site AG dinucleo- 
tide. {Top) DNA templates derived from pSP64-p2(7/8) linear- 
ized with PstI. The position of the branchpoint sequences (BPS) 
and adjacent polypyrimidine tract (shaded box) in intron 6 are 
also indicated. In vitro splicing reactions were carried out for 2 
hr and the a2P-labeled RNA products were separated in a 4% 
denaturing polyacrylamide g l. Schematic representation f the 
products and intermediates are indicated to the left of the auto- 
radiographs and are (from top to bottom) pre-mRNA, free lariat, 
and free exon 5. (Lanes M) Markers using pBR322 digested with 
MspI. To see free exon 5, it was necessary to photograph the 
autoradiograph at two exposures; hence, the break in the film 
above free exon 5. The free lariat formed using the wild-type 
precursor does not resolve from the unspliced precursor in this 
gel. The isolated free lariat was analyzed by primer extension 
using a a2P-labeled oligonucleotide complementary to se- 
quences in intron 6 {right). Part of the RNA was treated with 
debranching activity from an S-100 fraction prior to reverse 
transcription. Analyses of branched RNA (+) and debranched 
RNA ( - ) for each pre-mRNA are indicated. The positions of the 
lariat branch nucleotides, located 144, 147, and 153 nucleo- 
toides upstream of the 3' splice site of the wild-type precursor, 
are indicated. The band of 396 nucleotides corresponding tothe 
5' end of the linearized intron following treatment with de- 
branching activity is also indicated. 
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precursors derived from deletions d81 and d84 (see Fig. 2) 
linearized with PstI also did not undergo the first step in 
splicing (data not shown). Figure 6 (right) shows that the 
first step in splicing with all five substrates involves the 
use of the same branchpoints. Thus, the use of the 
branchpoints located upstream of exon 7 is specified in- 
dependently of the AG dincleotide of this 3' splice site. 
These results suggested that the branchpoints were 
specified by the polypyrimidine tract located immedi- 
ately downstream of the branch sites and that his tract 
is an important element for splice site utilization. To 
address this question further, we constructed a series of 
pre-mRNAs in which the polypyrimidine tract adjacent 
to the branch nucleotides was deleted from pSP64-p2(7/ 
8). The deletion mutants pSP64-p2(7/8)d92/cd22, pSP64- 
p2(7/8)d81/cd22, pSP64-p2(7/8)d84/cd22, and pSP64- 
p2(7/8)dlS/cd22 were obtained (Fig. 7). These deletions 
begin 94 nucleotides upstream of the 3' splice site of 
exon 7 and remove sequences toward the 5' end of intron 
6. The products of the in vitro splicing reactions with 
the wild-type and mutant pre-mRNAs are shown in 
Figure 7. Precursors derived from wild-type and pSP64- 
p2(7/8)d92/cd22, which contains 27 nucleotides of the 
polypyrimidine tract downstream of the branched nu- 
cleotides were spliced accurately and efficiently. In con- 
trast, the three precursors derived from pSP64-p2(7/ 
8)d81/cd22, d84/cd22, and d15/cd22, in which 8 nucleo- 
tides or less of the downstream polypyrimidine tract 
were present, were not spliced at all. These results indi- 
cate that the polypyrimidine tract located 89-143 nu- 
cleotides upstream of exon 7 represents an important 
cis-acting element. 
Removal of intron sequences upstream of exon 7 
results in use of the skeletal muscle-specific exon in 
nonmuscle cells 
The data described above demonstrate that splicing of 
exon 5 to 7 does not require most sequences between the 
3' splice site of exon 7 and the upstream branchpoints. 
However, it is possible that these sequences are involved 
in alternative splice site selection. The experiments de- 
scribed above used precursors in which there was no cis- 
competition between alternative splice sites (i.e., exons 
6 and 7) for upstream and downstream common exons. 
Accordingly, a series of deletions were introduced into 
plasmid pSV40-p2, which carries a minigene consisting 
of the SV40 early promoter and a functional poly(A) site 
flanking genomic tropomyosin sequences. We demon- 
strated previously that transient expression of plasmid 
pSV40-p2 in HeLa cells resulted in spliced RNA that 
contains exons 5 + 6 + 8 + 9 (Helfman et al. 1988). No 
other products were observed, and no RNAs were de- 
tected that contained exon 7. These results were ex- 
pected because HeLa cells express the same isoform as 
rat fibroblasts, namely TM-1 and, therefore, would not 
be expected to use exon 7. 
HeLa cells were transfected with the wild-type and six 
deletion mutant plasmids (d9, d29, d25, d92, d15, and 
d85), and the resulting transiently expressed cyto- 
Regulation of alternative RNA splicing 
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Figure 7. Deletion of the polypyrimidine tract affects pre- 
mRNA splicing. (Top) DNA templates derived from pSP64- 
p2(7/8) linearized with EcoRI. The position of the branchpoint 
sequences (BPS) and adjacent polypyrimidine tract (shaded box) 
in intron 6 are also indicated. The nucleotides removed in these 
deletions correspond to sequences in intron 6 and are shown in 
Fig. 2 from, -95 to -116 (d92/cd22); -95 to -135 (d81/cd22); 
-95 to -149 (d84/cd22); and -95 to -155 (cd15/cd22). In 
vitro splicing reactions were carried out for 2 hr and the 32P-la- 
beled RNA products were separated in a 4% denaturing poly- 
acrylamide gel. Schematic representation f the products and 
intermediates are indicated at the left and are (from top to 
bottom) pre-mRNA, lariat/exon intermediate, free lariat, free 
lariat but 3' end is degraded up until the lariat branchpoints by 
3' exonucleolytic activity, splice product, and free exon 5. 
(Lanes M) Markers using pBR322 digested with MspI. 
plasmic RNAs were isolated. The RNA protection anal- 
yses of these RNAs, as well as RNA isolated from mock- 
infected cells, were carried out using RNA probes de- 
rived from cDNA clones encoding rat fibroblast TM-1 
and skeletal muscle ~-tropomyosin (Fig. 8). Transient 
expression of wild-type plasmid pSV40-p2 in HeLa cells 
resulted in spliced RNA that contains exons 
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Splice P~ec l  (s) 
Figure 8. RNA analysis of HeLa cells transfected with tropo- 
myosin minigenes. (Top) Schematic diagram of the tropo- 
myosin minigenes used in the HeLa cell transfections. The po- 
sition of the branchpoint sequences (BPS) and adjacent polypyr- 
imidine tract (shaded box) in intron 6 are also indicated. 
(Middle) Autoradiographs of RNA protection analyses using 
probes derived from eDNA clones encoding rat fibroblast TM-1 
(left) and skeletal muscle [3-tropomyosin (right) of cytoplasmic 
RNAs from HeLa cells transfected with minigenes, as indi- 
cated. The band corresponding to the reference ~-globin RNAs 
is labeled (o~-globin). (Bottom) Schematic diagram of the struc- 
ture of the RNA probe and protected fragments (labeled S in 
middle) corresponding to spliced RNA from the seven mini- 
genes. 
5 + 6 + 8 + 9 (Fig. 8) No other products were ob- 
served, and no RNAs were detected that contained exon 
7. Surprisingly, expression of pSV40-p2d9 in HeLa cells 
resulted in expression of two forms of spliced RNA: one 
containing exons 5 + 6 + 8 + 9 (fibroblast-type splice), 
and the other containing exons 5 + 7 + 8 + 9 (skeletal 
muscle-type splice). Expression of mutants d29, d25, and 
d92 exhibited only the skeletal muscle-type splice 
products, with no detectable use of the fibroblast-type 
splice products. On the other hand, transient expression 
of deletions d15 and d85 did not result in spliced RNA 
containing either the fibroblast or the skeletal muscle- 
type products. At present, the reason for a lack of inclu- 
sion of the fibroblast-type exon using these two dele- 
tions is unclear. The results presented in Figure 8, to- 
gether with the results presented earlier in this paper, 
indicate that intron sequences immediately upstream 
from the 3' splice site of exon 7 are not required for uti- 
lization of this splice site but function by influencing 
the choice of alternative splice sites by inhibiting the 
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use of the skeletal muscle-specific exon in nonmuscle 
cells. 
Discussion 
The results presented in this paper identify two distinct 
elements in the intron upstream of the internal skeletal 
muscle-specific exon (exon 7) of the rat [3-tropomyosin 
gene, which play a role in pre-mRNA splicing. The first 
element is a polypyrimidine tract located 89-143 nu- 
cleotides upstream of the 3' splice site. This polypyrimi- 
dine tract is required for the formation of the lariat 
branchpoints located 144-153 nucleotides upstream of 
the 3' splice site. The second element consists of intron 
sequences immediately upstream of the 3' splice site of 
exon 7, which play an important role in the selection of 
alternative splice sites. The identification of these two 
cis-acting elements raises some important questions 
concerning the general mechanism of branchpoint selec- 
tion and the role of the elements in the regulation of 
alternative splicing. 
Cis-acting elements involved in branchpoint location 
Most branch sites that have been mapped are located 
within 18-40 nucleotides of the 3' splice site (Gra- 
bowski et al. 1984; Padgett et al. 1984; Ruskin et al. 
1984; Zeitlin and Efstratiadis 1984; Konarska et al. 
1985; Reed and Maniatis 1985; Ruskin et al. 1985}. In 
addition, mutation of branch nucleotides was found to 
result in the use of cryptic branchpoints that were also 
always located within the 18-40 nucleotides upstream 
from the 3' splice site (Padgett et al. 1985; Ruskin et al. 
1985). These data have led to the conclusion that there is 
a distance constraint responsible for positioning the 
branchpoint no more than 40 nucleotides from the AG 
dinucleotide of a 3' splice site (for review, see Green 
1986). However, a number of recent studies have demon- 
strated the use of branchpoints located a relatively long 
distance from a 3' splice site of alternatively spliced 
viral and cellular genes. Splicing of adenovirus EIA 
RNA was found to use multiple branchpoints located 
51-59 nucleotides from the 3' splice site (Gattoni et al. 
1988). Splicing of oL-tropomyosin pre-mRNAs was found 
to be associated with the use of a single branch site lo- 
cated 177 nucleotides from the 3' sites (Smith and 
Nadal-Ginard 1989}, whereas altemative splicing of [3- 
tropomyosin pre-mRNAs was found to involve the use 
of multiple branchpoints located 144-153 nucleotides 
from a 3' splice site (Helfman and Ricci 1989). These 
studies raise the possibility that the use of branchpoints 
located a relatively long distance from a 3' splice site 
may be an essential feature of some alternatively spliced 
exons. Whether such distant branch sites are found in 
introns that are not associated with alternative splice 
site selections is unknown. 
The use of branchpoint sequences located far up- 
stream from a 3' splice raises a number of questions re- 
garding the cis-acting elements and cellular factors in- 
volved in the use of these unusual branchpoints. Pre- 
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vious studies have demonstrated that formation of the 
branch nucleotide involves the interaction of U2 snRNP 
with the pre-mRNA branchpoint sequences (Black et al. 
1985; Konarska and Sharp 1986; Bindereif and Green 
1987; Parker et al. 1987). Mutational analyses demon- 
strate that the sequence most important for the U2 
snRNP branch point interaction is not the nucleotides 
in the branch point region itself but, rather, the 3' splice 
site consensus including the polypyrimidine tract and 
AG dinucleotide {Ruskin and Green 1985; Chabot and 
Steitz 1987). Deletions or mutations in the 3' splice site 
decrease or abolish U2 snRNP binding and splicing com- 
plex formation (Frendewey and Keller 1985; Ruskin and 
Green 1985; Bindereif and Green 1986; Chabot and 
Steitz 1987). On the other hand, mutations in the 
branchpoint sequences generally are not associated with 
the loss of U2 snRNP binding but, instead, result in acti- 
vation of cryptic branchpoints (Padgett et al. 1985; 
Ruskin et al. 1985). In addition, the interaction f U2AF 
with the 3' splice site of a pre-mRNA requires the AG 
dinucleotide for efficient binding {Ruskin et al. 1988). 
These results demonstrate hat the sequences near the 
3' splice site are important for the interaction of U2 
snRNP at a given branchpoint. 
The present studies address the nature of some of the 
cis-acting elements involved in the use of the branch- 
point sequences located 144-153 nucleotides upstream 
of the 3' splice site of exon 7 in the rat [3-tropomyosin 
gene. We demonstrated that a polypyrimidine tract lo- 
cated immediately downstream of a branch site func- 
tions as an important cis-acting element in branchpoint 
formation. Deletion of sequences between the 3' splice 
site and polypyrimidine tract had no effect on branch- 
point selection. In addition, we found that the positions 
of these branchpoints were specified independent of 
downstream exon sequences and the AG dinucleotide of
the 3' splice site. Even in the absence of the AG dinu- 
cleotide we were able to obtain the first step in splicing, 
that is, cleavage at the 5' splice site and formation of the 
lariat intermediate, as long as there was a polypyrimi- 
dine tract adjacent to he branchpoint sequences (Fig. 6). 
These data indicate that a polypyrimidine tract down- 
stream of a branch sequence can function independently 
of a 3' splice site in branch site selection. A similar po- 
lypyrimidine tract has been found adjacent to the 
branchpoint, which is located 177 nucleotides upstream 
of the 3' splice site of exon 3 of the rat a-tropomyosin 
gene {Smith and Nadal-Ginard 1989). Furthermore, the 
use of this branchpoint was found to be specified by the 
adjacent polypyrimidine tract, independent of the 3' 
splice site (C.W.J. Smith and B. Nadal-Ginard, pers. 
comm.). In a number of tropomyosin genes, we have ob- 
served relatively long polypyrimidine tracts located in 
the intron upstream of an alternatively spliced exon 
(Ruiz-Opazo and Nadal-Ginard 1987; Clayton et al. 
1988; Wieczorek et al. 1988; Helfman and Ricci 1989; 
Libri et al. 1989). These include exons 3, 8, 10, and 11 of 
the rat a-tropomyosin gene (Ruiz-Opazo and Nadal- 
Ginard 1987; Wieczorek et al. 1988), exons 8 of the 
human slow a-tropomyosin gene {Clayton et al. 1988), 
exon 7 and 10 of the rat f~-tropomyosin gene (Helfman 
and Ricci 1989; S. Erster and D. Helfman, unpubl.) and 
exons 6b and 10 of the chick B-tropomyosin gene (Libri 
et al. 1989). In the future, it will be of interest o deter- 
mine what role, if any, these sequences play in the use of 
these alternatively spliced exons. 
Our current model is that the polypyrimidine tract ad- 
jacent to the branch sites specifies the position of the 
lariat branchpoint. Following formation of the lariat/ 
exon intermediate during the first step in splicing, the 
splicing machinery selects the first downstream AG din- 
ucleotide, which defines the 3' splice site. In this respect 
it is worth noting that there are no AG dinucleotides 
between the branchpoints and the authentic AG dinu- 
cleotide of the 3' splice site of exon 7. Whether the same 
splicing factors are responsible for the use of those 
branchpoints located near (<40 nucleotides) versus 
those located far (>40 nucleotides) from a 3' splice site is 
not known. For example, although U2AF has been re- 
ported to require the AG dinucleotide at the 3' splice 
site, the presence of a long polypyrimidine tract may, 
itself, function as a binding site for U2AF. Alternatively, 
other factors may interact with the pre-mRNA in this 
region. 
Function of distant branch sites m splicing 
The functional significance of branch sites situated far- 
ther than 40 nucleotides from a 3' splice site is not fully 
understood. In one case the use of a branch site located a 
long distance from a 3' splice site was found to play an 
important role in alternative splice site selection. Alter- 
native splicing of the rat cx-tropomyosin gene involves 
mutually exclusive use of exons 2 and 3. These two 
exons are never spliced together in any cell type. The 
intron between exons 2 and 3 is 218 nucleotides in 
length. Interestingly, the branchpoint used upstream of 
exon 3 was found to be located 177 nucleotides from the 
3' splice site of this exon {Smith and Nadal-Ginard 
1989). This branch site is positioned only 42 nucleotides 
from the 5' splice site of exon 2. As a result of the rela- 
tively short distance between the 5' splice site of exon 2 
and this branch site, exon 2 is unable to splice to exon 3, 
presumably because the proximity of the 5' splice site 
and branchpoint results in steric hindrance, thereby pre- 
venting splicing factors from interacting with these 
splice sites. In contrast, this mechanism cannot explain 
the mutually exclusive use of exons 6 and 7 in alterna- 
tive splicing of the rat [3-tropomyosin gene. The lariat 
branchpoints located upstream of exon 7 are 136-147 
nucleotides from the 5' splice site of exon 6. Thus, a 
model based simply on steric hindrance cannot explain 
the lack of splicing of exon 6 to exon 7. Therefore, the 
locations of these branch sites are likely to play a dif- 
ferent role in alternative splicing of the B-tropomyosin 
gene. The results presented in this paper indicate that 
the primary role of sequences immediately upstream of 
the 3' splice site of exon 7 {skeletal muscle-type splice) 
is to influence the selection of alternative xons. Re- 
moval of these sequences resulted in the use of the skel- 
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etal muscle-specific exon in nonmuscle cells (Fig. 8). It 
should also be noted that the presence of regulatory se- 
quences between a branch site and a 3' splice site in- 
volved in altemative splicing is not restricted to those 
cases associated with the use of distant branchpoints. 
For example, studies of alternative splicing of SV40 
large-T and small-t pre-mRNAs demonstrated that mu- 
tations in the sequences immediately upstream of the 
shared 3' splice site had substantial effects on the use of 
ahemative 5' splice sites (Fu et al. 1988). In this case, 
splicing involves the use of multiple branch sites located 
within 18-32 nucleotides of the 3' splice site (Noble et 
al. 1987). Thus, the use of branchpoints located far up- 
stream from a 3' splice site may be a feature of some 
introns to provide space for regulatory sequences be- 
tween a lariat branch site and a 3' splice site. 
Role of intron sequences in regulation of alternative 
splicing 
The mechanism by which the intron sequences immedi- 
ately upstream of exon 7 play a role in alternative splice 
site selection is not known. One way in which these se- 
quences could regulate splice site selection is by binding 
to factor(sl in nonmuscle cells that inhibit the use of this 
3' splice site. Thus, deleting those sequences that bind 
to a negative-acting factor would consequently ead to 
activation of the splice site. Such a mechanism, or so- 
called blockage model, has been proposed for the regula- 
tion of a number of altematively spliced genes, in- 
cluding the transformer gene and the suppressor of 
white apricot gene of Drosophila melanogaster {Chou et 
al. 1987; Zachar et al. 1987; Sosnowski et al. 19891. 
However, the blockage model cannot explain the regula- 
tion of the rat B-tropomyosin gene described in this 
study. For example, by using precursors without dele- 
tions in intron 6, we were able to detect splicing of exon 
5 to exon 7 both in vitro and in vivo (present studies and 
Helfman et al. 1988}. Therefore, it is unlikely that a neg- 
ative-acting factor simply binds only to the 3' splice site 
of exon 7 and prevents its use in nonmuscle cells. On 
the other hand, a factor bound to sequences at the 3' 
splice site of exon 7 might function by preventing the 
use of the 5' splice site of this exon. Such a mechanism 
would be consistent with the observation that the 
splicing of exon 5 to exon 7 in nonmuscle cells requires 
that exon 7 first be spliced to exon 8 (Helfman et al. 
1988). 
A second way in which these sequences may regulate 
splice site selection is by participating in the formation 
of RNA secondary structures that sequester this exon 
and prevent its utilization in nonmuscle cells. RNA sec- 
ondary structure has been suggested to play a role in al- 
ternative RNA splicing by regulating the accessibility of 
different splice sites to the splicing machinery (Khoury 
et al. 1979; Munroe 1984; Solnick 1985; Eperon et al. 
1986, 1988; Edlind et al. 1987). Deleting sequences im- 
mediately upstream of exon 7 might prevent he forma- 
tion of RNA structures that normally block the use of 
this exon in nonmuscle cells. We have analyzed the pos- 
sible secondary structures that can form in this region of 
the pre-mRNA by using a computer program (Zucker 
and Stiegler 1981). Computer analysis of possible RNA 
secondary structure involving intron sequences up- 
stream and downstream of the skeletal muscle exon re- 
veals that this exon may be sequestered in a stable 
hairpin structure (G = -93.2 kcal/mole) (Fig. 9). The 
sequences analyzed in Figure 9 include 70 nucleotides 
upstream of exon 7 and 39 nucleotides downstream. We 
also analyzed sequences including 160 nucleotides up- 
stream of exon 7 (which comprise the polypyrimidine 
tract and branchpoint sequences) through 126 nucleo- 
tides downstream and have found a predicted structure 
of -196.5 kcal (data not shown). The sequences ana- 
lyzed in Figure 9 correspond to those sequences up- 
stream of exon 7 which, when deleted, resulted in use of 
the skeletal muscle exon in nonmuscle cells. Although 
the use of computer algorithms are not without limitia- 
tions, it is worth noting that analysis of intron se- 
quences of the same isogene from chick reveals a similar 
secondary structure that could sequester this exon (Libri 
et al. 1989). Thus, on the basis of computer analysis, 
there is phylogenetic conservation of these structures. 
Additional data consistent with the hypothesis that 
these intron sequences may function via RNA secondary 
structures comes from our previous studies demon- 
strating that splicing of exon 5 to exon 7 in nonmuscle 
cells required that exon 7 first be joined to the down- 
stream common exon (Helfman et al. 1988). Joining 
exons 7 and 8 and thereby removing the flanking intron 
may have prevented the formation of RNA secondary 
structures that interfered with the interactions of 
splicing factors with the splice sites of exon 7. 
Possible mechanisms for alternative splice site 
selection 
The data in the present studies demonstrate hat intron 
sequences upstream of exon 7 act as a negative regula- 
tory element preventing the use of this exon in non- 
muscle cells, possibly by participating in the formation 
of an RNA structure that sequesters this exon. Non- 
Energy  o f  s t ruc ture  = -93 .2  kca l  
d29 d9 
L I 
cgucgucgc  acugucuca  - u ucacg  au  ug  acacg  . . . .  u agU/~.AUG -~ U . . . . . . . . . . .  ~ - UGh. 
gc  ca  cccc  ccucac  ug  gccc  cucc  cc  cc  cc  cc  gc  UGGG CC AGAG GG AGC A 
cg  gu  gggg ggagug gc  cggg  gagg  gg  gg  gG GG CG ACCC GG UCUC CC UUG A 
. . . . . . . .  c u c . . . . . . .  aa  u . . . . . . . . . . .  auau  AACA . . . . . . . .  A GAA - UAAAGUUCAACAA A UUA 
Figure 9. Computer-predicted structure that could sequester the skeletal muscle specific exon. Sequences of xon 7 are shown in 
uppercase letters. Intron sequences upstream and downstream ofthis exon are indicated in lowercase letters. The positions of dele- 
tions from the 3' end of intron 6 are indicated (d9, d29). 
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muscle cells could express factors that interact with the 
RNA and inhibit the use of exon 7. Alternatively, skel- 
etal muscle could express factors that destabilize an 
RNA structure and thereby lead to uti l ization of this 
exon. Such factors could be RNA-binding proteins that 
act stoichiometrically b binding to the RNA or they 
could act catalytically, such as an RNA helicase. For ex- 
ample, a protein that has homology to a family of pre- 
sumed RNA helicases was found to be required for 
splicing of the mitochondrial cytochrome b (cob) and 
cytochrome c oxidase subunit (cox 1) genes (Seraphin et 
al. 1989). Interestingly, this protein was not required for 
splicing of all introns in these genes but only specific 
introns. Such an intron-specific RNA helicase could, in 
principle, lead to tissue-specific alternative splice site 
selection. In addition, an activity that destabilizes RNA 
helices has been found in a number of heterogeneous 
nuclear RNP (hnRNP) preparations (Razziuddin et al. 
1982; Thomas et al. 1983; Valentini et al. 1985; Drey- 
fuss 1986). On the other hand, a factor may simply bind 
to the pre-mRNA and prevent he formation of a sec- 
ondary structure. For example, a number of hnRNP pro- 
teins have been found to bind to the 3' end of introns 
(Swanson et al. 1988). Factors may bind to the 3' end of 
intron 6 of the rat f3-tropomyosin gene and inhibit the 
formation of an RNA structure that would sequester 
this exon. It is also worth noting that if RNA secondary 
structure does play a role in alternative splicing, mecha- 
nisms of regulation do not have to be l imited to factors 
interacting solely with the pre-mRNA. Work by Eperon 
et al. (1988) has suggested that there is a critical period 
in which an RNA can fold after transcription, which 
could contribute to the regulation of tissue-specific 
splicing if the rate of transcription along a gene was sub- 
ject to regulatory control. For example, if, in skeletal 
muscle, the RNA polymerase w re to pause during the 
transcription of sequences upstream and downstream of
exon 7, this could provide time for cellular factors to in- 
teract with the pre-mRNA and thereby prevent the RNA 
from forming a structure that prevents its use in non- 
muscle cells. 
In conclusion, having identified an important cis- 
acting element in the regulation of alternative splice site 
selection, we are now in a position to ask how these se- 
quences contribute mechanistically to tissue-specific 
splicing. Further work will be required to precisely de- 
fine the sequences involved in splice site selection. We 
also hope to determine whether muscle and nonmuscle 
cells express cell-type-specific actors that interact with 
sequences surrounding exon 7. 
Exper imenta l  procedures 
Plasmid constructions 
The DNA templates for use in in vitro transcription are derived 
from the rat [3-tropomyosin gene (Helfman et al. 1986). pSP64- 
p2(7/8) was described in detail elsewhere (Helfman et al. 1988). 
Plasmids containing deletions from the 3' end of intron 6 to- 
ward the 5' end of the intron were obtained from pSP64-p2(7/8) 
by first digesting pSP64-p2(7/8) with PstI. The DNA was then 
treated with BAL-31 nuclease, and the Klenow fragment of 
DNA polymerase I to generate blunt ends, followed by ligation 
to PstI linkers. Plasmids pSp64-p2(7/8) d9, d29, d25, d92, d84, 
d81, dlS, and d85 were obtained by ligating the NcoI-PstI frag- 
ments from the various deletions to the NcoI-PstI sites of 
pSP64-p2(7/8). The NcoI site is located in the middle of exon 6. 
All deletions from the 3' end of the intron maintained the last 7 
nucleotides ofintron 6. Plasmids containing deletions from the 
5' end of intron 6 toward the 3' end of the intron were obtained 
from pSP64-p2(7/8) by first digesting pSP64-p2(7/8) with StuI. 
The StuI site in intron 6 is located 17 bp downstream ofthe 5' 
splice site of exon 6. Therefore, these deletions from the 5' end 
of the intron maintain the first 17 nucleotides of intron 6. Then 
the DNA was treated with BAL-31 nuclease and the Klenow 
fragment of DNA polymerase I to generate blunt ends, followed 
by ligation to ClaI linkers. Plasmids pSP64-p2(7/8)cdwt (wild 
type), cd21, cd3, cdl4, cd30, cd27, and cd22 were obtained by 
ligating the ClaI-PstI fragments from the various deletions to 
the ClaI-PstI sites of pSP64-p2(7/8)cdwt. The sequences of all 
deletions were determined by DNA sequence analysis (Sanger 
et al. 1977) and are shown in Figure 2. 
For studies designed to analyze the internal alternatively 
spliced region of the rat f~-tropomyosin gene, i  vivo plasmids 
pSV40-p2(7/8) and pSV40-p2 were used (Helfman et al. 1988). 
The deletions prepared from the 5' and 3' ends of intron 6 de- 
scribed above were subcloned into plasmids pSV40-p2(7/8) and 
pSV40-p2. In all transfection studies HeLa cells were cotrans- 
fected with an c~-globin test gene (Treisman et al. 1983). 
Synthesis of RNA and in vitro splicing 
The a2p-labeled SP6/tropomyosin transcripts weresynthesized 
in vitro, primed with Cap analog, as described (Konarska et al. 
1984). The a2P-labeled pre-mRNAs contained a small amount of 
prematurely terminated transcripts, but their presence did not 
appear to affect the in vitro splicing reactions, and the RNA 
substrates were not purified further. 
HeLa cell nuclear extracts were prepared as described 
(Dignam et al. 1983; Krainer et al. 1984). In vitro splicing reac- 
tions were carried out at 30°C for indicated times (0-240 min). 
Standard assay conditions used for these studies consisted of 15 
~1 of nuclear extract in a final reaction volume of 25 ~1, con- 
taining 1 mM MgC12, 500 ~M ATP, 20 mM creatine phosphate, 
2.7% (wt/vol) polyvinyl alcohol, 15-30 ng pre-mRNA, 12.8 rnM 
HEPES (pH 8), 14% (vol/vol) glycerol, 60 mM KC1, 0.12 mM 
EDTA, and 0.7 mM dithiothreitol (DTT). 
Analysis of processing products 
After incubation (for indicated time), the reactions were 
stopped by addition of a solution containing SDS-proteinase K, 
and the RNA was recovered, as described (Krainer et al. 1984). 
The products of the reaction were analyzed on denaturing urea- 
polyacrylamide g ls. Intermediates were distinguished from 
final products by their relative appearance and disappearance in 
time course xperiments. Lariat RNAs were identified by their 
aberrant mobility on different percentage polyacrylamide g ls 
(Grabowski et al. 1984; Ruskin et al. 1984). In addition, RNAs 
containing lariats were verified by treatment by a lariat de- 
branching activity (Ruskin and Green 1985). Processing 
products were also analyzed by primer extension a alysis. 
Primer extension analysis was carried out essentially as de- 
scribed (Ghosh et al. 1978; Erster tal. 1988; Helfman and Ricci 
1989). An oligodeoxynucleotide (5'-AGGAGGAGAAAA- 
GAGAA-3'), complementary to sequences in intron 6 located 
119-135 nucleotides from the 3' splice site of exon 7, was used 
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as a primer. The primer was end-labeled with [~/-32P]ATP, using 
T4 polynucleotide kinase. The primer was annealed to the 
RNA by incubation for 3 min at 55°C, followed by 30 min at 
37°C in 30 ~1 of primer extension buffer [50 mM Tris-HC1 (pH 
8.3), 140 mM KC1, 10 mM MgC12]. For primer extension, reac- 
tions were transferred to 42°C and supplemented with DTT 
(final concentration of 5 rnM), deoxynucleotide triphosphates 
(final concentration of 0.5 mM) and 10 units of avian myelob- 
lastosis virus reverse transcriptase. After 30 min, the reactions 
were terminated by addition of EDTA to a final concentration 
of 25 mM, and the radiolabeled pre-mRNA was degraded by 
treatment with RNase A prior to gel electrophoresis. 
Transfections and RNA analysis 
HeLa cells were grown in Dulbecco's modified Eagle medium 
(DMEM] supplemented with 10% fetal bovine serum (FBS). 
HeLa cells were transfected with 5 ~g of tropomyosin plasmid 
DNA and 1 ~g of e~-globin test plasmid [Treisman et al. 1983) 
per 100-mm plate, using a calcium phosphate coprecipitation 
procedure, and the cells were harvested 48 hr later. The a- 
globin plasmid served as an intemal control for transformation 
efficiency. For preparation of cytoplasmic RNA, each 100-mm 
plate of HeLa cells was washed three times with ice-cold PBS, 
and the cells were scraped from the plates with a rubber po- 
liceman in 1ml of PBS and transferred to a microfuge tube. The 
cells were centrifuged for 15 sec and resuspended in 375 ~1 of 
ice-cold buffer containing 150 mM NaC1, 1.5 mM MgC12, and 10 
mM Tris-HC1 (pH 8.0), 10% NP-40 was added to a final concen- 
tration of 0.5% to lyse the cells. The nuclei were pelleted by 2 
min of centrifugation i the cold room, and the supematant 
was transferred to a clean tube containing 4 ~1 of 10% SDS and 
5 ~1 of proteinase K (10 mg/ml). The mixture was incubated at 
37°C for 15 min and extracted with phenol, and the nucleic 
acids were precipitated with ethanol. The RNA preparations 
were then treated with DNase in the presence of RNasin and 
reprecipitated. 
RNase protection assays were carried out as described (Zinn 
et al. 1983). The plasmids used for synthesis of 32p-labeled anti- 
sense RNA were derived from cDNA clones encoding rat fibro- 
blast TM-1 and skeletal muscle B-tropomyosin (Yamawaki-Ka- 
taoka and Helfman 1985; Helfman et al. 1986). The plasmids 
were prepared by inserting the PstI-ClaI fragments of the fibro- 
blast and skeletal muscle cDNA clones into pSP64. The PstI 
site, corresponding to amino acids 144 in exon 4, was modified 
with EcoRI linkers, and the ClaI site, corresponding to amino 
acids 252 in exon 9, was modified with HindIII linkers. The 
resulting EcoRI-HindIII fragments were ligated into an EcoRI- 
HindIII double-cut pSP64 vector. Plasmid was linearized with 
EcoRI and transcribed with SP6 polymerase to yield a transcript 
of -330 nucleotides. Because the transfected genes do not con- 
tain sequences in exon 4, it was possible to distinguish RNA 
derived from the transfected genes from endogenous mRNA. 
Hybridizations contained 10 p.g of total cytoplasmic RNA, 
500,000 cpm of tropomyosin probe, and 500,000 cpm of a- 
globin anti-sense probes (Herr and Clarke 1986) in a total 
volume of 30 ~1. All subsequent steps were carried out as de- 
scribed previously (Zinn et al. 1983), except he RNase diges- 
tions were carried out at 30°C for 60 min. 
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